127 related articles for article (PubMed ID: 8071943)
1. Novel synthesis of cyclic amide-linked analogues of angiotensins II and III.
Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Gatos D; Ganter R; Moore D; Moore GJ
J Med Chem; 1994 Sep; 37(18):2958-69. PubMed ID: 8071943
[TBL] [Abstract][Full Text] [Related]
2. Conformational restriction of angiotensin II: cyclic analogues having high potency.
Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR
J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273
[TBL] [Abstract][Full Text] [Related]
3. The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II.
Matsoukas JM; Polevaya L; Ancans J; Mavromoustakos T; Kolocouris A; Roumelioti P; Vlahakos DV; Yamdagni R; Wu Q; Moore GJ
Bioorg Med Chem; 2000 Jan; 8(1):1-10. PubMed ID: 10968258
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.
Matsoukas JM; Agelis G; Hondrelis J; Yamdagni R; Wu Q; Ganter R; Smith JR; Moore D; Moore GJ
J Med Chem; 1993 Apr; 36(7):904-11. PubMed ID: 8464045
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of new side chain and backbone cyclic bradykinin analogues.
Schumann C; Seyfarth L; Greiner G; Paegelow I; Reissmann S
J Pept Res; 2002 Aug; 60(2):128-40. PubMed ID: 12102726
[TBL] [Abstract][Full Text] [Related]
7. Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.
Johannesson P; Lindeberg G; Johansson A; Nikiforovich GV; Gogoll A; Synnergren B; Le Grèves M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2002 Apr; 45(9):1767-77. PubMed ID: 11960488
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.
Hondrelis J; Matsoukas J; Cordopatis P; Ganter RC; Franklin KJ; Moore GJ
Int J Pept Protein Res; 1991 Jan; 37(1):21-6. PubMed ID: 2045217
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
Goghari MH; Franklin KJ; Moore GJ
J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902
[TBL] [Abstract][Full Text] [Related]
11. New cyclic bradykinin antagonists containing disulfide and lactam bridges at the N-terminal sequence.
Seyfarth L; Pineda de Castro LF; Liepina I; Paegelow I; Liebmann C; Reissmann S
Int J Pept Protein Res; 1995 Aug; 46(2):155-65. PubMed ID: 8567170
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis.
Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis IP; Mavromoustakos T; Moore GJ; Matsoukas JM
J Med Chem; 1999 Apr; 42(7):1170-7. PubMed ID: 10197961
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
14. A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin II.
Scanlon MN; Matsoukas JM; Franklin KJ; Moore GJ
Life Sci; 1984 Jan; 34(4):317-21. PubMed ID: 6546405
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and biological activity of cyclic analogs of angiotensin].
Bisenietse DA; Antsans IuE; Myshliakova NV; Kublik GG; Porunkevich EA
Bioorg Khim; 1987 Feb; 13(2):149-59. PubMed ID: 2437929
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.
Schmidt B; Lindman S; Tong W; Lindeberg G; Gogoll A; Lai Z; Thörnwall M; Synnergren B; Nilsson A; Welch CJ; Sohtell M; Westerlund C; Nyberg F; Karlén A; Hallberg A
J Med Chem; 1997 Mar; 40(6):903-19. PubMed ID: 9083479
[TBL] [Abstract][Full Text] [Related]
18. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-chain bridges. Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonists.
Roumelioti P; Polevaya L; Zoumpoulakis P; Giatas N; Mutule I; Keivish T; Zoga A; Vlahakos D; Iliodromitis E; Kremastinos D; Grdadolnik SG; Mavromoustakos T; Matsoukas J
Bioorg Med Chem Lett; 2002 Sep; 12(18):2627-33. PubMed ID: 12182875
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
Moore GJ; Oudeman EM; Ko D; Nystrom DM
J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
